Aurinia Pharmaceuticals
AUPH
AUPH
210 hedge funds and large institutions have $499M invested in Aurinia Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 66 increasing their positions, 58 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+13
Holders Change %
+6.6%
% of All Funds
2.85%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
66
Reduced
58
Closed
20
Calls
$14.4M
Puts
$7.71M
Net Calls
+$6.66M
Net Calls Change
+$10.2M
Top Buyers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$12.9M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$6.05M |
| 3 |
Morgan Stanley
New York
|
+$5.81M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.31M |
| 5 |
Lazard Asset Management
New York
|
+$5.22M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$11.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.63M |
| 3 |
Citigroup
New York
|
-$4.49M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.81M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.82M |
